Skip to main content Skip to search Skip to main navigation

Data Integrity in the QC Laboratory

Excerpt from the GMP Compliance Adviser, Chapter 14.L, Data integrity in the quality control laboratory

5 min. reading time | by Markus Veit, PhD 
Published in LOGFILE 22/2025 

Data integrity plays a particularly important role in pharmaceutical quality control as the results generated here are the basis of product quality assessment and thus are relevant for batch release. This article explains, which data arise during HPLC analytics and how the ALCOA principles are linked to the process of data generation.


This article deals with the practical aspects of implementing the European requirements for data integrity. A HPLC laboratory for pharmaceutical quality control is used as an example in which data for the batch release of a finished medicinal product is generated. How does the release process work and what kind of data is generated? 

For batch certification the test results generated by quality control are compared to the specifications in the authorisation documents and subsequently filed in a Certificate of Analysis (CoA). 

In case of test results meeting the specifications, the batch can be released; the release is documented in the release register. It is part of the GMP documentation where all testing data is collected.

Data integrity requirements


What types of data occur in a chromatography laboratory is shown in Figure 1. The list does not claim to be exhaustive.

Data in a chromatography laboratory
  • data from the tested batch and data on personnel who carry out and control the testing process
  • sampling and sample storage data, records and observations
  • weighing and sample preparation data, standards and reagents used
  • qualification and calibration data for the pipettes and balances used
  • qualification data for all the devices used
  • instrument control data (detector wavelength range, flow, temperature, etc.)
  • sequence data in full
  • data to be recorded (e.g. data rate, integration parameters, etc.)
  • chromatography testing data (initial electronic data, peak areas)
  • processed data from chromatography testing (processed electronic data)
  • measuring process and device-specific calibrations
  • device-specific calculations
  • peak areas after integration
  • HPLC calibration data
  • calculation data (software-based or completed manually)
  • trend analyses
  • all system suitability test results
  • reports generated from electronic data (sample-list printouts, chromato-grams, etc.)
  • audit trail data and all deviations and changes
  • documented observations
  • calculations external to the device, if applicable, carried out using external software (LIMS, Excel) = derived data, results (reportable result), evalua-tion (with OOS, OOE, OOT)

Figure 1 | Data in a chromatography laboratory


All of this data should comply with the ALCOA principles – and, in an ideal situation, the extended ALCOA plus („ALCOA++“) principles (see Figure 2).

ALCOA Principles
  • Attributable

  • Legible

  • Contemporaneous

  • Original

  • Accurate

ALCOA++ Principles
  • Complete
  • Consistent
  • Enduring
  • Available
  • Traceable

Figure 2 | ALCOA / ALCOA++ principles of data integrity


A number of these requirements listed in Figure 2 are already contained in the EU GMP Guidelines, i.e. they are not newly introduced by the publication of data integrity specifications. In particular, the traceability of data connects the ALCOA elements (McDowall, R. D.: Is Traceability the Glue for ALCOA, ALCOA+, or ALCOA++? in: Spectroscopy, April 2022, Volume 37, Issue 4, p. 13–19; https://doi.org/10.56530/spectroscopy.up8185n1).

Adequate traceability


Key aspects of data integrity in the chronological order of data generation are examined below. 

Data on sampling and the handling of samples is frequently stored in a LIMS. In practice, however, hybrid systems are also used. When this is the case, special care must be taken to ensure that data is properly transferred. Data on sample preparation and preparation for chromatographic determination is generally documented on paper. Not all of the data must be transferred to the LIMS; however, it is important to ensure that the batch-related traceability of data does not depend on the type of documentation used. During chromatographic determination, only electronic data is generated. It is read in the form of integrated chromatograms and the resulting peak areas. Subsequent manual reintegration is not always avoidable and continues to be a controversial aspect with regard to data integrity.

The further processing of data during evaluation can be carried out using integrated evaluation software, LIMS or external programs. Different aspects of data integrity need to be observed. This is a common source of non-compliance that is often not recognised by the operator and/or cannot be influenced by him/her and also explains why the au-thorities stipulate that an audit trail review must be carried out prior to batch release.

When a report is generated, it must be ensured that it is an original document, regardless of whether it is paper-based or electronic. The storage and archiving of data must also be regulated in detail so that the data is protected against subsequent manipulation, unauthorised access or loss. It must also be ensured that the data can be retrieved and remains legible for the entire mandatory period of retention. 

Non-compliance with data integrity requirements e.g. result from insufficient access controls, incomplete qualification and validation, errors during audit trail review or during handling of changes and deviations.

For process development compliance with data integrity is not required comprehensively. Nevertheless, basic requirements e.g. data accuracy has to be fulfilled to achieve reli-able results. This includes correct handling of statistical analysis. 

Data integrity is a critical and very complex topic. Comprehensive trainings for everyone involved in the processes thus are mandatory. Compliance with data integrity should be reviewed by regular self-inspections.


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Dr. Markus Veit
Dr. Markus Veit

You may also be interested in the following articles:

News: EMA

EMA Clarifies Batch Numbering for Parallel-Traded Medicines

EMA updated its GMP/GDP Q&A collection by revising the answer to Question 4 concerning Chapter 5 of the EU GMP Guide. It explains which batch numbers should appear on the packaging of parallel-traded medicines.

Read more
Question of the Week | GMP-Verlag

Why is it Important to use Consistent Microbiological Air Monitoring Methods in Pharmaceutical Cleanrooms?

Here's the answer:
Read more
Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Robust PDE reports form the basis of risk-based cleaning validation. This article highlights common deficiencies identified during GMP inspections and explains how they can be avoided.

Read more
News: Europe

EDQM: New Working Party on 3D-printed Medicinal Products

The European Pharmacopoeia Commission (EPC) approved the creation of a working party on 3D-printed medicinal products. Its aim is to support the development of appropriate quality standards in the European Pharmacopoeia (Ph. Eur.).
Read more
EMA: 14 New Nitrosamines for Appendix 1

EMA: 14 New Nitrosamines for Appendix 1

Appendix 1 of EMA’s Questions and Answers on nitrosamine impurities has been updated. This appendix contains acceptable intakes (AIs) established for N-nitrosamines.
Read more
WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO published a revised draft of its “WHO guidelines on quality risk management”. Working document QAS/26.994 is open for public comment until 15 November 2026.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

With an named user licence, one user can access the knowledge portal; with a corporate licence, any number of users can access it.Approx. 5,000 pages of practical GMP knowledge with illustrations and forms: Practical guidance for rapid implementation in the workplaceDetailed descriptions of GMP-compliant systemsInternational laws and guidelines Always up-to-date thanks to regular updates Download Advantages and Prices60+ Sample Documents In addition, the GMP Compliance Adviser contains more than 60 sample documents (MS Office) and practical examples that you can use.Sample SOPsSample FormsSample ReportsSample DocumentationChecklistsProcess Diagrams (Flowcharts)Practical Examples of QRM Application (e.g., Risk Analyses)Sample Documents for Qualification and ValidationCase StudiesWritten by more than 80 authors with hands-on experience directly linked to the industryA team of over 80 experts interpret regulatory requirements and describe how they are implemented in practice.The authors are experienced in the pharmaceutical industry, consulting, and government agencies.

delivery immediately after receipt of payment
€1,368.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics.  It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery immediately after receipt of payment
€610.00 net excl. VAT
E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment
€245.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment
€44.90 net excl. VAT